Dengvaxia
®
induces antibody responses in dengue virus (DENV)-naïve children, but the durability of these responses and their impact on subsequent wild-type (WT) DENV infection remain unclear. Although previous studies have primarily evaluated vaccine efficacy against dengue disease, the impact of Dengvaxia
®
on...
M. Abad-Fernández, J. Daag, L. D. Hein et al.· Frontiers in Immunology· 0 citations
There are currently no effective vaccines against Zika virus (ZIKV). Candidate vaccines target the ZIKV envelope (E) protein, the major target of anti-ZIKV neutralizing antibodies (nAbs). Here, we utilized DNA and RNA platforms to compare virus-like particle vaccines with premembrane (prM) and E expressed either in the...
Kantinan Chuensirikulchai, Qin-Hui Li, Hsueh-Han Lu et al.· Nature Microbiology· 0 citations
BACKGROUND
Currently the role of dengue virus (DENV) specific T cell responses in disease pathogenesis and protection are not well understood, including potential differences in those who have obesity. We sought to investigate the functionality and phenotype of T cells in patients with acute dengue fever (DF) or dengue...
H. Kuruppu, M. De Silva, Chathumini Dissanayake et al.· Clinical and Experimental Im...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.